Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CSF1R | P07333 | 12/20 | 0.83 |
| ▸ | BRAF | P15056 | 3/20 | 0.63 |
| ▸ | CYP11B2 | P19099 | 2/20 | 0.60 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.57 |
| ▸ | NPC1 | O15118 | 1/20 | 0.57 |
| ▸ | RAB9A | P51151 | 1/20 | 0.57 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3934893 | 0.94 | CSF1R (0.85) | CSF1RBRAFCYP11B2L3MBTL1 | |
| SCHEMBL3938937 | 0.92 | CSF1R (0.86) | CSF1RBRAF | |
| SCHEMBL3934183 | 0.91 | CSF1R (1.00) | CSF1RBRAFNPC1RAB9AL3MBTL1 | |
| SCHEMBL3929957 | 0.91 | CSF1R (0.78) | CSF1RBRAF | |
| SCHEMBL3943702 | 0.89 | CSF1R (0.70) | CSF1RBRAFCYP11B2L3MBTL1 | |
| SCHEMBL3931994 | 0.88 | CSF1R (0.65) | CSF1RBRAFCYP11B2CYP11B1L3MBTL1 | |
| SCHEMBL3932812 | 0.86 | CSF1R (1.00) | CSF1RBRAFCYP11B2NPC1 | |
| SCHEMBL3934829 | 0.86 | BRAF (0.83) | CSF1RBRAFCYP11B2CYP11B1 | |
| SCHEMBL3936075 | 0.86 | CSF1R (1.00) | CSF1RBRAFCYP11B2CYP11B1NPC1 | |
| SCHEMBL1276793 | 0.84 | CSF1R (1.00) | CSF1RBRAF |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1831198-B1 | PYRIDINE CARBOXAMIDE DERIVATIVES FOR USE AS ANTICANCER AGENTS | ASTRAZENECA AB (SE) | 2009-04-08 | — | — | EP | disclosed |